Infectious Disease Comorbidities Adversely Affecting Substance Users With HIV: Hepatitis C and Tuberculosis
- 1 December 2010
- journal article
- other
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 55 (Supplement) , S37-S42
Abstract
The linkage between drug use, particularly injection drug use, and HIV/AIDS, hepatitis C (HCV), and tuberculosis (TB) has been recognized since the beginning of the HIV pandemic. These comorbid conditions affect drug users worldwide and act synergistically, with resultant adverse biologic, epidemiologic, and clinical consequences. Prevention, care, and treatment of TB and HCV can be successful, and both diseases can be cured. Special clinical challenges among drug users, however, can result in increased morbidity, mortality, and decreased therapeutic success. Among these are limited disease screening, inadequate and insensitive diagnostics, difficult treatment regimens with varying toxicities, and complicated pharmacokinetic and pharmacodynamic drug interactions. These may result in delayed diagnosis, deferred treatment initiation, and low completion rates, with the potential for generation and transmission of drug resistant organisms. Strategies to address these challenges include outreach programs to engage substance abusers in nonmedical settings, such as prisons and the streets, active screening programs for HIV, HCV, and TB, increased and broadened clinician expertise, knowledge and avoidance of drug interactions, attention to infection control, use of isoniazid preventive therapy, and creative strategies to insure medication adherence. All of these require structural changes directed at comprehensive prevention and treatment programs and increased collaboration and integration of needed services for substance abusers.Keywords
This publication has 41 references indexed in Scilit:
- HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early MortalityAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Hepatitis C Virus Is Infrequently Evaluated and Treated in an Urban HIV Clinic PopulationAIDS Patient Care and STDs, 2009
- Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment programJournal of Substance Abuse Treatment, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Tuberculosis and Substance Abuse in the United States, 1997-2006Archives of internal medicine (1960), 2009
- Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004Clinical Infectious Diseases, 2008
- Limited Uptake of Hepatitis C Treatment Among Injection Drug UsersJournal of Community Health, 2007
- Integration and co-location of HIV/AIDS, tuberculosis and drug treatment servicesInternational Journal of Drug Policy, 2007
- Liver-Related Deaths in Persons Infected With the Human Immunodeficiency VirusArchives of internal medicine (1960), 2006
- Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985–2002HIV Medicine, 2006